Browsing by Author Buxton, MJ

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 50  next >
Issue DateTitleAuthor(s)
2009Assessing the impact of England's National Health Service R&D Health Technology Assessment program using the "payback" approachRaftery, J; Hanney, S; Green, C; Buxton, MJ
2008Assessing the impact of health technology assessment in the NetherlandsOortwijn, WJ; Hanney, S; Ligtvoet, A; Hoorens, S; Wooding, S, et al
2010Assessing the payback from health R & D: From ad hoc studies to regular monitoringBuxton, MJ; Croxson, B; Hanney, S
2008Clinical and cost-effectiveness analysis of an open label, single-centre, randomised trial of spinal cord stimulation (SCS) versus percutaneous myocardial laser revascularisation (PMR) in patients with refractory angina pectoris: The SPiRiT trialDyer, MT; Goldsmith, KA; Khan, SN; Sharples, LD; Freeman, C, et al
2012Cost-effectiveness of a European preventive cardiology programme in primary care: A Markov modelling approachMistry, H; Morris, S; Kotseva, K; Wood, D; Buxton, MJ
2008The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trialHenriksson, M; Epstein, DM; Palmer, SJ; Sculpher, MJ; Clayton, TC, et al
1992Cost effectiveness of the implantable cardioverter defibrillator: a preliminary analysisO'Brien, BJ; Buxton, MJ; Rusby, RA
1989Cost minimisation study of transdermal glyceryl trinitrate in reducing failures of peripheral intravenous infusionKhawaja, HT; O'Brien, BJ; Buxton, MJ; Weaver, PC
1996Costs and cost effectiveness of cardiovascular screening and intervention: The British family heart studyWonderling, D; McDermott, C; Buxton, MJ; Kinmonth, AL; Pyke, S, et al
2012Current use and potential value of cost-effectiveness analysis in U.S. health care: The case of medicare national coverage determinationsBuxton, MJ; Lord, J; Morris, S; Chambers, James
2011The demand for sports and exercise: Results from an illustrative surveyAnokye, NK; Pokhrel, S; Buxton, MJ; Fox-Rushby, J
2010Developing and applying a framework for assessing the payback from medical researchHanney, S; Buxton, MJ
2008Developing the protocol for the evaluation of the health foundation's 'engaging with quality initiative' – an emergent approachSoper, B; Buxton, MJ; Hanney, S; Oortwijn, W; Scoggins, A, et al
1995Economic evaluation in intensive care: The case of SDDBuxton, MJ; Elliott, Rachel
2007Economic evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost-effective compared to an atenolol-based regimenLindgren, P; Buxton, MJ; Kahan, T; Poulter, NR; Dahlof, B, et al
2008Economic evaluation of ASCOT-BPLA: Antihypertensive treatment with an amlodipine-based regimen is cost effective compared with an atenolol-based regimenLindgren, P; Buxton, MJ; Kahan, T; Poulter, NR; Dahlof, B, et al
2001Economic evaluation of health care technologies: A comparison of alternative decision modelling techniquesBuxton, MJ; Brown, J; Karnon, Jonathan Daniel
1996Economic evaluation of minimal access surgery: The case of surgical treatment for menorrhagiaBuxton, MJ; Drummond, M; Sculpher, Mark John
1992Economic evaluation of ondansetron: Preliminary analysis using clinical trial data prior to price settingBuxton, MJ; O'Brien, BJ
2011Economic issues associated with the operation and evaluation of telemedicineBuxton, MJ; Mistry, Hema